IMPROVING ONCOLOGY INVESTIGATION WITH BUILT-IN KRAS ASSAY SOLUTIONS AND RAS ASSAYS

within the quickly evolving area of oncology analysis, correct and efficient mutation screening is vital for producing focused therapies. The KRAS companies System performs a pivotal part Within this landscape by featuring in depth answers for KRAS mutation profiling and analysis. KRAS mutations, found in roughly ninety five% of RAS-connected oncog